Accessibility Menu
Canopy Growth logo

Canopy Growth

(NASDAQ) CGC

Current Price$0.93
Market Cap$398.71MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2014)-97%
5 Year-100%
1 Year-13%
1 Month-3%
Canopy Growth last closing stock price
MetricPriceDate
Last closeUSD 0.952026-07-15
Canopy Growth stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-1.25%USD 0.972026-07-08
1 month-3.04%USD 0.982026-06-15
3 month-17.13%USD 1.152026-04-16
Year to date-16.4%USD 1.142025-12-31
1 year-12.57%USD 1.092025-07-15
3 year-75.19%USD 3.842023-07-14
5 year-99.51%USD 195.802021-07-16
Since inception-97.11%USD 33.002014-04-07

Canopy Growth Financials at a Glance

Market Cap

$398.71MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

CA$312.34M

Net Income (TTM)

-CA$286.21M

EPS (TTM)

-$0.59

P/E Ratio

-1.62

Dividend

$0.00

Beta (Volatility)

2.00 (High)

Price

$0.93

Volume

2,736,570.785

Open

$0.95

Previous Close

$0.93

Daily Range

$0.92 - $0.97

52-Week Range

$0.84 - $2.38

Estimated Earnings Date

Aug 7, 2026

CGC: Motley Fool Moneyball Superscore

30

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Canopy Growth

Canopy Growth makes cannabis products for medical and recreational use. It helps patients manage health and adults find relaxation. The company sells flower, edibles, and high-quality vaporizer devices.

Flowers, Edibles, and Devices

  • Dried Flower: Standardized cannabis packaged as loose flower or pre-rolled joints for medical and adult consumers.
  • Extracts and Concentrates: Items including softgel capsules for precise dosing and traditional hash for experienced users.
  • Cannabis Edibles: Discreet, flavored products like gummies intended for long-term industry growth.
  • Vaporizer Devices: Precision-engineered medical and home herbal vaporizers manufactured under the Storz & Bickel brand.

Recent Moves and Big Plans

  • Acquired MTL Cannabis on March 16, 2026, to gain specialized indoor cultivation talent and new plant genetics.
  • Established Canopy USA to manage non-controlling interests in American brands including Wana, Jetty, and Acreage.
  • Re-introduced the Tweed brand into Germany in fiscal 2026 following changes in national cannabis laws.
  • Launched the Veazy portable vaporizer under the Storz & Bickel brand in September 2025.

What Sets Operations Apart

Canopy Growth uses an asset-right model that combines internal facilities with regional suppliers to stay flexible. It also runs a global safety program to track health effects across all its product lines.

A Look at the Numbers

  • Gross sales to Canadian cannabis control authorities were $130.2 million for the fiscal year ended March 31, 2026.
  • Market capitalization was $539 million in Q3 2025, up 24% year-over-year.
  • The company secured a senior secured term loan for US$150 million that was funded on January 8, 2026.
  • Canopy Growth raised approximately US$271.3 million by selling shares through equity programs in the fiscal year ended March 31, 2026.
  • The price-to-earnings ratio, which compares stock price to profit, was -2.2 in Q3 2025.

The Path Forward

Canopy Growth has shifted to a focused approach centered on high-margin brands and vaporizer technology. Its restructuring into two main segments reflects a push for profitability in global legal markets.

AI Generated • Jun 15, 2026

Industry

Pharmaceuticals

Employees

1,128

CEO

Luc Mongeau

Headquarters

Smiths Falls, ON K7A 0A8, CA

CGC Financials

Key Financial Metrics (TTM)

Gross Margin

22.18%

Operating Margin

-49.88%

Net Income Margin

-84.76%

Return on Equity

-35.48%

Return on Capital

-7.49%

Return on Assets

-23.56%

Earnings Yield

-61.73%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$398.71MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

418.37M

Volume

2.74M

Avg. Volume

8.71M

Financials (TTM)

Gross Profit

CA$77.66M

Operating Income

-CA$103.15M

EBITDA

-CA$205.34M

Operating Cash Flow

-CA$70.22M

Capital Expenditure

-CA$6.66M

Free Cash Flow

-CA$76.88M

Cash & ST Invst.

CA$364.68M

Total Debt

CA$278.71M

Canopy Growth Performance Analysis

Canopy Growth annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20232023-03-31CAD 251,914,041-38.1%
20242024-03-31CAD 220,299,074-12.5%
20252025-03-31CAD 193,391,074-12.2%
20262026-03-31CAD 205,921,2766.5%
Canopy Growth sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q12025-06-3010.9%
Q22025-09-30-7.6%
Q32025-12-3153.4%
Q42026-03-31-30.3%
Canopy Growth annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20232023-03-31CAD -53.44745.7%
20242024-03-31CAD -6.52-87.8%
20252025-03-31CAD -3.40-47.8%
20262026-03-31CAD -0.64-81.2%
Canopy Growth sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q12025-06-3084.6%
Q22025-09-3097.3%
Q32025-12-31-4066.7%
Q42026-03-31-60.0%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2026YOY CHG

Revenue

CA$71.25M

+9.6%

Gross Profit

CA$8.26M

-21.7%

Gross Margin

11.60%

N/A

Market Cap

$398.71MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$353.46K

N/A

Employees

1,128

N/A

Net Income

-CA$157.12M

+28.8%

EBITDA

-CA$137.00M

+29.5%

Quarterly Fundamentals

Name
Q4 2026YOY CHG

Total Cash

CA$364.68M

+177.4%

Total Debt

CA$278.71M

-20.0%

Accounts Receivable

CA$36.29M

-31.2%

Inventory

CA$110.51M

+14.7%

Long Term Debt

CA$248.15M

-24.3%

Short Term Debt

CA$30.56M

+46.9%

Return on Assets

-23.56%

N/A

Return on Invested Capital

-16.15%

N/A

Free Cash Flow

-CA$19.36M

+46.7%

Operating Cash Flow

-CA$18.25M

+44.9%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
CABACabaletta Bio, Inc.
$2.67-3.61%
LYELLyell Immunopharma, Inc.
$13.89-2.59%
TKNOAlpha Teknova, Inc.
$5.32+0.57%
OMIOwens & Minor, Inc.
$2.68+8.94%

Trending Stocks

Symbol / CompanyPricePrice Chg
ATAIAtaiBeckley
$7.15+0.33%
NOKNokia
$10.38-0.08%
ONDSOndas
$6.65-0.06%
PATHUiPath
$12.03+0.01%

Questions About CGC

What is the current price of Canopy Growth?

Canopy Growth is trading at $0.93 per share.

What is the 52-week range for Canopy Growth?

Over the past 52 weeks, Canopy Growth has traded between $0.84 and $2.38.

How much debt does Canopy Growth have?

As of the most recent reporting period, Canopy Growth reported total debt of CA$199.72M.

How much cash does Canopy Growth have on hand?

Canopy Growth reported CA$261.32M in cash and cash equivalents in its most recent financial results.

What is Canopy Growth’s dividend yield?

Canopy Growth does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.